Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05593588 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

StatusActive, Not Recruiting
PhasePhase 2
SponsorAvni Joshi
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion pushed from May 2026 to Dec 2026
    • Trial status changed: Enrolling by Invitation → Active, Not Recruiting
    v8
  2. Primary completion date: Dec 2025 to May 2026v7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary completion date: Dec 2024 to Dec 2025
    • Study completion date: Dec 2024 to Dec 2026
    v5
  5. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Mar 1, 2023 to Apr 12, 2023
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Jan 1, 2023 to Mar 1, 2023v3
  2. Start date: Dec 1, 2022 to Jan 1, 2023
    • Primary completion date: Dec 31, 2024 to Dec 2024
    • Study completion date: Dec 31, 2025 to Dec 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine if the supplement, Fisetin, can be used as a treatment option for common variable immunodeficiency (CVID) by comparing its efficacy to placebo.
Trial Details
NCT Number NCT05593588
Lead Sponsor Avni Joshi
Conditions
(from sponsor)		 Common Variable Immunodeficiency, Interstitial Lung Disease Due to Systemic Disease
Related terms Common Variable Immunodeficiency
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov